Team (TISI) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue was $228.6 million, down 4.5% year-over-year, but net loss improved to $2.8 million from $15.8 million in Q2 2023, driven by cost reductions and margin expansion.
Adjusted EBITDA rose 25% to $21.8 million (9.5% of revenue), reflecting improved operating leverage and lower overhead.
Operating income increased to $11.2 million from $4.6 million, with significant progress in cost reduction and margin improvement.
Leadership remains focused on operational execution, commercial initiatives, and strengthening the balance sheet.
The company continues to address NYSE listing compliance and ongoing litigation.
Financial highlights
Gross margin dollars increased to $63.6 million (27.8% of revenue), up 240 basis points year-over-year.
Adjusted EBITDA for Q2 2024 was $21.8 million, up from $17.4 million in Q2 2023.
Net loss for the quarter was $2.8 million ($0.63/share), a $13 million improvement over the prior year.
Cash and cash equivalents at June 30, 2024 were $22.5 million, with total debt and finance obligations of $320.1 million.
Free cash flow for the six months ended June 30, 2024 was negative $10.2 million.
Outlook and guidance
Full-year 2024 Adjusted EBITDA guidance is $58–68 million, a 48% increase at the midpoint over 2023.
Reaffirmed 2024 revenue guidance of $850–$900 million and gross margin guidance of $235–$265 million.
Expecting top-line growth and further margin improvement in the second half of 2024, with strong activity in both core and international segments.
Management believes current working capital, forecasted cash flows, and available credit are sufficient to fund operations and service debt.
Clear path to achieving 10%+ Adjusted EBITDA margin in the near future.
Latest events from Team
- 2026 meeting covers director elections, compensation, auditor, warrant issuance, and equity plan.TISI
Proxy filing24 Mar 2026 - Revenue, operating income, and adjusted EBITDA rose, margins improved, and debt was reduced.TISI
Q4 202513 Mar 2026 - Q3 2024 revenue and margins improved, but guidance was lowered amid ongoing liquidity and NYSE risks.TISI
Q3 202415 Jan 2026 - Margins and EBITDA improved in 2024, with refinancing extending debt maturities to 2030.TISI
Q4 202426 Dec 2025 - Registering 1.45M shares for resale post-$75M private placement, supporting recapitalization.TISI
Registration Filing16 Dec 2025 - Key votes include director elections, auditor ratification, and a charter amendment on director removal.TISI
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, pay, auditor ratification, and governance updates.TISI
Proxy Filing2 Dec 2025 - Flat Q1 revenue, $29.7M net loss, and refinancing set up at least 15% EBITDA growth for 2025.TISI
Q1 202525 Nov 2025 - Q2 revenue rose 8.5% to $248.0M, Adjusted EBITDA up 12.4%, with margin gains and transformation underway.TISI
Q2 202523 Nov 2025